Background & Sources: Clinical evidence review: Reglan and Tardive Dyskinesia

An organized set of primary and secondary sources covering clinical background, drug-safety signals, and patient-safety considerations.

Recommended deep-dive

Clinical evidence review: Reglan and Tardive Dyskinesia: Key Facts & Context

A focused review of background, context, and source material on this subject.

ClinicalTrials.gov

Reference: ClinicalTrials.gov

Authoritative source for clinical, regulatory, and public-health background reading.

U.S. Food and Drug Administration (FDA)

Reference: U.S. Food and Drug Administration (FDA)

Authoritative source for clinical, regulatory, and public-health background reading.

Centers for Disease Control and Prevention (CDC)

Reference: Centers for Disease Control and Prevention (CDC)

Authoritative source for clinical, regulatory, and public-health background reading.